mp:V9.2.0 kwalificatie medicatiegegevens MGB addendum: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
Regel 130: | Regel 130: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA1_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 9 dagen om 23:59:59 uur | |style="background-color: white;"|T + 9 dagen om 23:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 stuks, Oraal | |style="background-color: white;"|2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 stuks | |style="background-color: white;"|2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 211: | Regel 204: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA2_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA2_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA2_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 68 dagen om 23:59:59 uur | |style="background-color: white;"|T - 68 dagen om 23:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Nee | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1fa2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fa2-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1fa2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fa2-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Informant | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1fb1-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fb1-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1fb1-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fb1-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1fc2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fc2-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1fc2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fc2-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard-HPK') | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard-HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|10 stuks, Oraal | |style="background-color: white;"|10 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|10 stuks | |style="background-color: white;"|10 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden gebruik |
|style="background-color: white;"|op voorschirft | |style="background-color: white;"|op voorschirft | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA1__MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_QA1__MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 302: | Regel 281: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA3_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur | |style="background-color: white;"|T - 9 dagen om 07:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 maal per dag 50 ml, oraal | |style="background-color: white;"|2 maal per dag 50 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 50 ml | |style="background-color: white;"|2 maal per dag 50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 383: | Regel 355: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA4_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 21 dagen om 08:12 uur | |style="background-color: white;"|T + 21 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 3 stuks, oraal | |style="background-color: white;"|1 maal per dag 3 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 3 stuks | |style="background-color: white;"|1 maal per dag 3 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MA | |style="background-color: white;"|MBH_920_QA4_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 457: | Regel 422: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA5_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA5_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA5_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 43 dagen om 08:00 uur | |style="background-color: white;"|T - 43 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d21d6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21d6-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d21d6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21d6-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d21e6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21e6-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d21e6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21e6-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 1 stuk, oraal | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 528: | Regel 489: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA6_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA6_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA6_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 2 dagen om 08:59:59 uur | |style="background-color: white;"|T + 2 dagen om 08:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d0734-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0734-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d0734-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0734-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d0746-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0746-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d0746-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0746-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|OXAZEPAMOXAZEPAM TABLET 10MG TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|OXAZEPAMOXAZEPAM TABLET 10MG TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 maal per dag 2 stuks, oraal | |style="background-color: white;"|2 maal per dag 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 2 stuks | |style="background-color: white;"|2 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA6_MA | |style="background-color: white;"|MBH_920_QA6_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 1.027: | Regel 981: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA1_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 9 dagen om 23:59:59 uur | |style="background-color: white;"|T + 9 dagen om 23:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 stuks, Oraal | |style="background-color: white;"|2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 stuks | |style="background-color: white;"|2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 1.211: | Regel 1.158: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA4_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 21 dagen om 08:12 uur | |style="background-color: white;"|T + 21 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 3 stuks, oraal | |style="background-color: white;"|1 maal per dag 3 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 3 stuks | |style="background-color: white;"|1 maal per dag 3 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MA | |style="background-color: white;"|MBH_920_QA4_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 1.382: | Regel 1.322: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA1_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 9 dagen om 23:59:59 uur | |style="background-color: white;"|T + 9 dagen om 23:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 stuks, Oraal | |style="background-color: white;"|2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 stuks | |style="background-color: white;"|2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 1.463: | Regel 1.396: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA3_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur | |style="background-color: white;"|T - 9 dagen om 07:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 maal per dag 50 ml, oraal | |style="background-color: white;"|2 maal per dag 50 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 50 ml | |style="background-color: white;"|2 maal per dag 50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 1.544: | Regel 1.470: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA4_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 21 dagen om 08:12 uur | |style="background-color: white;"|T + 21 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 3 stuks, oraal | |style="background-color: white;"|1 maal per dag 3 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 3 stuks | |style="background-color: white;"|1 maal per dag 3 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MA | |style="background-color: white;"|MBH_920_QA4_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 1.618: | Regel 1.537: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA6_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA6_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA6_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 2 dagen om 08:59:59 uur | |style="background-color: white;"|T + 2 dagen om 08:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d0734-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0734-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d0734-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0734-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d0746-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0746-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d0746-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d0746-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|OXAZEPAMOXAZEPAM TABLET 10MG TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|OXAZEPAMOXAZEPAM TABLET 10MG TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 maal per dag 2 stuks, oraal | |style="background-color: white;"|2 maal per dag 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 2 stuks | |style="background-color: white;"|2 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA6_MA | |style="background-color: white;"|MBH_920_QA6_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 1.970: | Regel 1.882: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA2_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA2_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA2_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 68 dagen om 23:59:59 uur | |style="background-color: white;"|T - 68 dagen om 23:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Nee | |style="background-color: white;"|Nee | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1fa2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fa2-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1fa2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fa2-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Informant | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1fb1-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fb1-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1fb1-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fb1-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1fc2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fc2-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1fc2-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1fc2-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard-HPK') | |style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard-HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|10 stuks, Oraal | |style="background-color: white;"|10 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|10 stuks | |style="background-color: white;"|10 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden gebruik |
|style="background-color: white;"|op voorschirft | |style="background-color: white;"|op voorschirft | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA1__MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_QA1__MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 2.061: | Regel 1.959: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA3_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur | |style="background-color: white;"|T - 9 dagen om 07:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 maal per dag 50 ml, oraal | |style="background-color: white;"|2 maal per dag 50 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 50 ml | |style="background-color: white;"|2 maal per dag 50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 2.142: | Regel 2.033: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA5_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA5_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA5_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 43 dagen om 08:00 uur | |style="background-color: white;"|T - 43 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d21d6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21d6-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d21d6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21d6-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d21e6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21e6-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d21e6-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d21e6-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 1 stuk, oraal | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 2.460: | Regel 2.347: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA1_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 9 dagen om 23:59:59 uur | |style="background-color: white;"|T + 9 dagen om 23:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 stuks, Oraal | |style="background-color: white;"|2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 stuks | |style="background-color: white;"|2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 2.541: | Regel 2.421: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA3_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur | |style="background-color: white;"|T - 9 dagen om 07:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d206a-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d207c-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 maal per dag 50 ml, oraal | |style="background-color: white;"|2 maal per dag 50 ml, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 50 ml | |style="background-color: white;"|2 maal per dag 50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 2.622: | Regel 2.495: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA4_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 21 dagen om 08:12 uur | |style="background-color: white;"|T + 21 dagen om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2123-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d2132-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|(code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 3 stuks, oraal | |style="background-color: white;"|1 maal per dag 3 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 3 stuks | |style="background-color: white;"|1 maal per dag 3 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA4_MA | |style="background-color: white;"|MBH_920_QA4_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 2.910: | Regel 2.776: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_QA1_MGB-JNK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 9 dagen om 23:59:59 uur | |style="background-color: white;"|T + 9 dagen om 23:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eed-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | |style="background-color: white;"|Zie [[#uuid_891d1eff-d990-11eb-1977-020000000000|Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 stuks, Oraal | |style="background-color: white;"|2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 stuks | |style="background-color: white;"|2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 3.132: | Regel 2.991: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_start_eind_MGB-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_start_eind_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_start_eind_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 6 dagen om 10:59:59 uur | |style="background-color: white;"|T + 6 dagen om 10:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9bdbe-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bdbe-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9bdbe-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bdbe-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9bdd0-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bdd0-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9bdd0-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bdd0-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaar HPK') | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaar HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 stuk, oraal | |style="background-color: white;"|1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 stuk | |style="background-color: white;"|1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 3.316: | Regel 3.168: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_start_duur_MGB-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_start_duur_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_start_duur_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T + 22 dagen om 12:00 uur | |style="background-color: white;"|T + 22 dagen om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9be76-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9be76-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9be76-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9be76-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3 | + | |colspan="3"|Zorgverlener |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|style="background-color: white;"|Zie [[#uuid_89e9be87-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9be87-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9be87-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9be87-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 1 stuk, oraal | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_start_duur-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_start_duur-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 3.500: | Regel 3.345: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_start_duur2_MGB-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_start_duur2_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_start_duur2_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 32 dagen om 15:21:33 uur | |style="background-color: white;"|T - 32 dagen om 15:21:33 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9c068-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9c068-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9c068-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9c068-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9c07a-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9c07a-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9c07a-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9c07a-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 1 stuk, oraal | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_start_duur2_MA | |style="background-color: white;"|MBH_920_start_duur2_MA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_start_duur2-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_start_duur2-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 3.687: | Regel 3.525: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_chronisch_MGB-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_chronisch_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_chronisch_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 20 dagen om 11:43:12 uur | |style="background-color: white;"|T - 20 dagen om 11:43:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9bf5f-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bf5f-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9bf5f-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bf5f-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9bf70-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bf70-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9bf70-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9bf70-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|1 maal per dag 1 stuk, oraal | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_chronisch-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_chronisch-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 3.874: | Regel 3.705: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_dosis_stuks_MGB-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_dosis_stuks_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_dosis_stuks_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 100 dagen om 07:59:59 uur | |style="background-color: white;"|T - 100 dagen om 07:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9a5ca-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5ca-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9a5ca-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5ca-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Informant is patient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9a5dc-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5dc-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9a5dc-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5dc-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|2 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|2 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 dosis | |style="background-color: white;"|2 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
Regel 4.061: | Regel 3.885: | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_920_inf_pers_MGB-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
|style="background-color: white;"|MBH_920_inf_pers_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |style="background-color: white;"|MBH_920_inf_pers_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatiegebruik datum tijd |
|style="background-color: white;"|T - 100 dagen om 07:59:59 uur | |style="background-color: white;"|T - 100 dagen om 07:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruik indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Volgens afspraak indicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' | |style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
|style="background-color: white;"|T - 130 dagen | |style="background-color: white;"|T - 130 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
|style="background-color: white;"|T - 101 dagen | |style="background-color: white;"|T - 101 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9a5ca-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5ca-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9a5ca-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5ca-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Informant |
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Contactpersoon |
|style="background-color: white;"|Zie [[#ContactPersoonBartJansen|Contactpersoon: ContactPersoonBartJansen]] | |style="background-color: white;"|Zie [[#ContactPersoonBartJansen|Contactpersoon: ContactPersoonBartJansen]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Auteur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#uuid_89e9a5dc-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5dc-d990-11eb-1053-020000000000]] | |style="background-color: white;"|Zie [[#uuid_89e9a5dc-d990-11eb-1053-020000000000|Zorgverlener: uuid_89e9a5dc-d990-11eb-1053-020000000000]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | |style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|2 maal per dag 1 dosis | |style="background-color: white;"|2 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
|style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
|style="background-color: white;"|MBH_920_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_920_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} |
Versie van 1 jul 2021 17:55
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset 0
Scenario | Screenshots? | Beschrijving |
0.1 | Alle medicatieafspraken van de patiënt, zonder aanvullende filter criteria (Antwoord: bericht met 6 medicatieafspraken) | |
0.2 | Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_920_QA1_MGB" invoeren) (Antwoord: bericht met 1 medicatiegebruik) | |
0.3 optioneel | Medicatiegebruik met een filter op product code (PRK 3956) (Antwoord: bericht met 1 medicatiegebruik) | |
0.4 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 4 medicatieafspraken) | |
0.5 | Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 medicatieafspraken) | |
0.6 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 3 medicatieafspraken) | |
0.7 | Medicatiegebruik met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_920_QA1" invoeren) (Antwoord: bericht met 1 medicatiegebruik) | |
0.8 | Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder medicatieafspraken) |
1.1.2 Scenarioset 1
Scenario | Screenshots? | Beschrijving | MBH id | MGB id |
1.1* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum). | Medicatiegebruik gebruiksperiode ingangsdatum en einddatum | MBH_920_start_eind-BSC | MBH_920_start_eind_MGB-BSC |
1.2a* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Medicatiegebruik gebruiksperiode ingangsdatum en duur (weken) | MBH_920_start_duur-BSC | MBH_920_start_duur_MGB-BSC |
1.2b* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Medicatiegebruik gebruiksperiode ingangsdatum en duur (dagen) | MBH_920_start_duur2-BSC | MBH_920_start_duur2_MGB-BSC |
1.3 | Medicatiegebruik gebruiksperiode ingangsdatum (chronische medicatie) | MBH_920_chronisch-BSC | MBH_920_chronisch_MGB-BSC | |
1.4 | Medicatiegebruik met eenheid 'dosis/stuks' | MBH_920_dosis_stuks-BSC | MBH_920_dosis_stuks_MGB-BSC | |
1.5 | Medicatiegebruik met contactpersoon als informant | MBH_920_dosis_stuks-BSC | MBH_920_inf_pers_MGB-BSC |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
1.2.1 Scenarioset 0
Scenario | Beschrijving |
0.1 | Alle medicatieafspraken van de patiënt, zonder aanvullende filter criteria (Antwoord: bericht met 6 medicatieafspraken) |
0.2 | Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_920_QA1_MGB" invoeren) (Antwoord: bericht met 1 medicatiegebruik) |
0.3 | Medicatiegebruik met een filter op product code (PRK 3956) (Antwoord: bericht met 1 medicatiegebruik) |
0.4 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 4 medicatieafspraken) |
0.5 | Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 medicatieafspraken) |
0.6 | Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 3 medicatieafspraken) |
0.7 | Medicatiegebruik met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_920_QA1" invoeren) (Antwoord: bericht met 1 medicatiegebruik) |
0.8 | Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder medicatieafspraken) |
1.2.2 Scenarioset 1
Scenario | Beschrijving | MBH id | MGB id |
1.1 | Medicatiegebruik gebruiksperiode ingangsdatum en einddatum | MBH_920_start_eind-BSC | MBH_920_start_eind_MGB-BSC |
1.2a | Medicatiegebruik gebruiksperiode ingangsdatum en duur (weken) | MBH_920_start_duur-BSC | MBH_920_start_duur_MGB-BSC |
1.2b | Medicatiegebruik gebruiksperiode ingangsdatum en duur (dagen) | MBH_920_start_duur2-BSC | MBH_920_start_duur2_MGB-BSC |
1.3 | Medicatiegebruik gebruiksperiode ingangsdatum (chronische medicatie) | MBH_920_chronisch-BSC | MBH_920_chronisch_MGB-BSC |
1.4 | Medicatiegebruik met eenheid 'dosis/stuks' | MBH_920_dosis_stuks-BSC | MBH_920_dosis_stuks_MGB-BSC |
1.5 | Medicatiegebruik met contactpersoon als informant | MBH_920_dosis_stuks-BSC | MBH_920_inf_pers_MGB-BSC |
1.3 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.3.1 Scenario 0.1 - MBH_920_QA1-JNK
Medicatiegebruik MBH_920_QA1_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 9 dagen om 23:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.2 Scenario 0.1 - MBH_920_QA2-JNK
Medicatiegebruik MBH_920_QA2_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA2_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 68 dagen om 23:59:59 uur | ||
Gebruik indicator | Nee | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1fa2-d990-11eb-1977-020000000000 | ||
Informant | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1fb1-d990-11eb-1977-020000000000 | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1fc2-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard-HPK') | ||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 10 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 10 stuks | ||
Reden gebruik | op voorschirft | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA1__MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.3 Scenario 0.1 - MBH_920_QA3-JNK
Medicatiegebruik MBH_920_QA3_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 9 dagen om 07:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 50 ml, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 50 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.4 Scenario 0.1 - MBH_920_QA4-JNK
Medicatiegebruik MBH_920_QA4_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 21 dagen om 08:12 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000 | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 3 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 3 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA4_MA | ||
MBH identificatie | MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.5 Scenario 0.1 - MBH_920_QA5-JNK
Medicatiegebruik MBH_920_QA5_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA5_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 43 dagen om 08:00 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d21d6-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d21e6-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.6 Scenario 0.1 - MBH_920_QA6-JNK
Medicatiegebruik MBH_920_QA6_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA6_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 2 dagen om 08:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d0734-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d0746-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | OXAZEPAMOXAZEPAM TABLET 10MG TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 2 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA6_MA | ||
MBH identificatie | MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.7 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_891d1eed-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1ef6-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1eff-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1f09-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1fa2-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1fab-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1fb1-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1fbb-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1fc2-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1fcc-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d206a-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2073-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d207c-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2086-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d2123-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d212c-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d2132-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d213b-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d21d6-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d21df-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d21e6-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d21f0-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d0734-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d073d-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d0746-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d0750-d990-11eb-1977-020000000000 | |||
Zorgaanbieder met id: uuid_891d1ef6-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk | |||
Zorgaanbieder met id: uuid_891d1f09-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d1fab-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d1fbb-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d1fcc-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2073-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2086-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) | |||
Zorgaanbieder met id: uuid_891d212c-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d213b-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) | |||
Zorgaanbieder met id: uuid_891d21df-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 0100 (in identificerend systeem: URA) | |||
Organisatie naam | 0100 | |||
Zorgaanbieder met id: uuid_891d21f0-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) | |||
Zorgaanbieder met id: uuid_891d073d-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d0750-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) |
1.4 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.4.1 Scenario 0.2 - MBH_920_QA1-JNK
Medicatiegebruik MBH_920_QA1_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 9 dagen om 23:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_891d1eed-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1ef6-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1eff-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1f09-d990-11eb-1977-020000000000 | |||
Zorgaanbieder met id: uuid_891d1ef6-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk | |||
Zorgaanbieder met id: uuid_891d1f09-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners |
1.5 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.5.1 Scenario 0.3 - MBH_920_QA4-JNK
Medicatiegebruik MBH_920_QA4_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 21 dagen om 08:12 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000 | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 3 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 3 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA4_MA | ||
MBH identificatie | MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_891d2123-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d212c-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d2132-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d213b-d990-11eb-1977-020000000000 | |||
Zorgaanbieder met id: uuid_891d212c-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d213b-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) |
1.6 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.6.1 Scenario 0.4 - MBH_920_QA1-JNK
Medicatiegebruik MBH_920_QA1_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 9 dagen om 23:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.2 Scenario 0.4 - MBH_920_QA3-JNK
Medicatiegebruik MBH_920_QA3_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 9 dagen om 07:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 50 ml, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 50 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.3 Scenario 0.4 - MBH_920_QA4-JNK
Medicatiegebruik MBH_920_QA4_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 21 dagen om 08:12 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000 | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 3 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 3 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA4_MA | ||
MBH identificatie | MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.4 Scenario 0.4 - MBH_920_QA6-JNK
Medicatiegebruik MBH_920_QA6_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA6_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 2 dagen om 08:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d0734-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d0746-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | OXAZEPAMOXAZEPAM TABLET 10MG TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 2 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA6_MA | ||
MBH identificatie | MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.5 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_891d1eed-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1ef6-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1eff-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1f09-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d206a-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2073-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d207c-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2086-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d2123-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d212c-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d2132-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d213b-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d0734-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d073d-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d0746-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d0750-d990-11eb-1977-020000000000 | |||
Zorgaanbieder met id: uuid_891d1ef6-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk | |||
Zorgaanbieder met id: uuid_891d1f09-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2073-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2086-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) | |||
Zorgaanbieder met id: uuid_891d212c-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d213b-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) | |||
Zorgaanbieder met id: uuid_891d073d-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d0750-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) |
1.7 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.7.1 Scenario 0.5 - MBH_920_QA2-JNK
Medicatiegebruik MBH_920_QA2_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA2_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 68 dagen om 23:59:59 uur | ||
Gebruik indicator | Nee | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1fa2-d990-11eb-1977-020000000000 | ||
Informant | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1fb1-d990-11eb-1977-020000000000 | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1fc2-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard-HPK') | ||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 10 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 10 stuks | ||
Reden gebruik | op voorschirft | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA1__MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.2 Scenario 0.5 - MBH_920_QA3-JNK
Medicatiegebruik MBH_920_QA3_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 9 dagen om 07:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 50 ml, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 50 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.3 Scenario 0.5 - MBH_920_QA5-JNK
Medicatiegebruik MBH_920_QA5_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA5_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 43 dagen om 08:00 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d21d6-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d21e6-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.4 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_891d1fa2-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1fab-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1fb1-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1fbb-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1fc2-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1fcc-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d206a-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2073-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d207c-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2086-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d21d6-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d21df-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d21e6-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d21f0-d990-11eb-1977-020000000000 | |||
Zorgaanbieder met id: uuid_891d1fab-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d1fbb-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d1fcc-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2073-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2086-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) | |||
Zorgaanbieder met id: uuid_891d21df-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 0100 (in identificerend systeem: URA) | |||
Organisatie naam | 0100 | |||
Zorgaanbieder met id: uuid_891d21f0-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) |
1.8 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.8.1 Scenario 0.6 - MBH_920_QA1-JNK
Medicatiegebruik MBH_920_QA1_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 9 dagen om 23:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.2 Scenario 0.6 - MBH_920_QA3-JNK
Medicatiegebruik MBH_920_QA3_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA3_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 9 dagen om 07:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d206a-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d207c-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 50 ml, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 50 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.3 Scenario 0.6 - MBH_920_QA4-JNK
Medicatiegebruik MBH_920_QA4_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA4_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 21 dagen om 08:12 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2123-d990-11eb-1977-020000000000 | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d2132-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 3 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 3 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA4_MA | ||
MBH identificatie | MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.4 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_891d1eed-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1ef6-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1eff-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1f09-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d206a-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2073-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d207c-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d2086-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d2123-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d212c-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d2132-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d213b-d990-11eb-1977-020000000000 | |||
Zorgaanbieder met id: uuid_891d1ef6-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk | |||
Zorgaanbieder met id: uuid_891d1f09-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2073-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d2086-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) | |||
Zorgaanbieder met id: uuid_891d212c-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_891d213b-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | (in identificerend systeem: URA) |
1.9 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.9.1 Scenario 0.7 - MBH_920_QA1-JNK
Medicatiegebruik MBH_920_QA1_MGB-JNK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_QA1_MGB-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 9 dagen om 23:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eed-d990-11eb-1977-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_891d1eff-d990-11eb-1977-020000000000 | ||
Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_QA1_NA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.9.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_891d1eed-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1ef6-d990-11eb-1977-020000000000 | |||
Zorgverlener met id: uuid_891d1eff-d990-11eb-1977-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_891d1f09-d990-11eb-1977-020000000000 | |||
Zorgaanbieder met id: uuid_891d1ef6-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk | |||
Zorgaanbieder met id: uuid_891d1f09-d990-11eb-1977-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners |
1.10 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | S. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Jankie | |||
Identificatienummer | 999910437 [BSN] | |||
Geboortedatum | 8 mei 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.11 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | A. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Boschman | |||
Identificatienummer | 999912100 [BSN] | |||
Geboortedatum | 8 jan 1964 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.11.1 Scenario 1.1 - MBH_920_start_eind-BSC
Medicatiegebruik MBH_920_start_eind_MGB-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_eind_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 6 dagen om 10:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9bdbe-d990-11eb-1053-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9bdd0-d990-11eb-1053-020000000000 | ||
Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaar HPK') | ||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_920_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.11.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_89e9bdbe-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9bdc7-d990-11eb-1053-020000000000 | |||
Zorgverlener met id: uuid_89e9bdd0-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9bdda-d990-11eb-1053-020000000000 | |||
Zorgaanbieder met id: uuid_89e9bdc7-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | 00001111 | |||
Zorgaanbieder met id: uuid_89e9bdda-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) |
1.12 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | A. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Boschman | |||
Identificatienummer | 999912100 [BSN] | |||
Geboortedatum | 8 jan 1964 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.12.1 Scenario 1.2a - MBH_920_start_duur-BSC
Medicatiegebruik MBH_920_start_duur_MGB-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T + 22 dagen om 12:00 uur | ||
Gebruik indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9be76-d990-11eb-1053-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9be87-d990-11eb-1053-020000000000 | ||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_start_duur-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.12.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_89e9be76-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9be7f-d990-11eb-1053-020000000000 | |||
Zorgverlener met id: uuid_89e9be87-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9be91-d990-11eb-1053-020000000000 | |||
Zorgaanbieder met id: uuid_89e9be7f-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_89e9be91-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners |
1.13 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | A. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Boschman | |||
Identificatienummer | 999912100 [BSN] | |||
Geboortedatum | 8 jan 1964 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.13.1 Scenario 1.2b - MBH_920_start_duur2-BSC
Medicatiegebruik MBH_920_start_duur2_MGB-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur2_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 32 dagen om 15:21:33 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9c068-d990-11eb-1053-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9c07a-d990-11eb-1053-020000000000 | ||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_duur2_MA | ||
MBH identificatie | MBH_920_start_duur2-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.13.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_89e9c068-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9c071-d990-11eb-1053-020000000000 | |||
Zorgverlener met id: uuid_89e9c07a-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9c084-d990-11eb-1053-020000000000 | |||
Zorgaanbieder met id: uuid_89e9c071-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_89e9c084-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners |
1.14 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | A. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Boschman | |||
Identificatienummer | 999912100 [BSN] | |||
Geboortedatum | 8 jan 1964 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.14.1 Scenario 1.3 - MBH_920_chronisch-BSC
Medicatiegebruik MBH_920_chronisch_MGB-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_chronisch_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 20 dagen om 11:43:12 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9bf5f-d990-11eb-1053-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9bf70-d990-11eb-1053-020000000000 | ||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_chronisch-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.14.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_89e9bf5f-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter vab Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9bf68-d990-11eb-1053-020000000000 | |||
Zorgverlener met id: uuid_89e9bf70-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9bf7a-d990-11eb-1053-020000000000 | |||
Zorgaanbieder met id: uuid_89e9bf68-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_89e9bf7a-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners |
1.15 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | A. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Boschman | |||
Identificatienummer | 999912100 [BSN] | |||
Geboortedatum | 8 jan 1964 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.15.1 Scenario 1.4 - MBH_920_dosis_stuks-BSC
Medicatiegebruik MBH_920_dosis_stuks_MGB-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_dosis_stuks_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 100 dagen om 07:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9a5ca-d990-11eb-1053-020000000000 | ||
Informant | |||
Informant is patient | Ja | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9a5dc-d990-11eb-1053-020000000000 | ||
Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 2 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 1 dosis | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.15.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener met id: uuid_89e9a5ca-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9a5d3-d990-11eb-1053-020000000000 | |||
Zorgverlener met id: uuid_89e9a5dc-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9a5e6-d990-11eb-1053-020000000000 | |||
Zorgaanbieder met id: uuid_89e9a5d3-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_89e9a5e6-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners |
1.16 MP KWALIFICATIE Medicatiegegevens MGB Scenarioset 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | A. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Boschman | |||
Identificatienummer | 999912100 [BSN] | |||
Geboortedatum | 8 jan 1964 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.16.1 Scenario 1.5 - MBH_920_dosis_stuks-BSC
Medicatiegebruik MBH_920_inf_pers_MGB-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_inf_pers_MGB-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Medicatiegebruik datum tijd | T - 100 dagen om 07:59:59 uur | ||
Gebruik indicator | Ja | ||
Volgens afspraak indicator | Ja | ||
Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | ||
Ingangsdatum | T - 130 dagen | ||
Einddatum | T - 101 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9a5ca-d990-11eb-1053-020000000000 | ||
Informant | |||
Contactpersoon | Zie Contactpersoon: ContactPersoonBartJansen | ||
Auteur | |||
Zorgverlener | Zie Zorgverlener: uuid_89e9a5dc-d990-11eb-1053-020000000000 | ||
Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 1 dosis | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.16.2 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Contactpersoon met id: ContactPersoonBartJansen | ||||
Naamgegevens | Bart Jansen | |||
Rol | ||||
Zorgverlener met id: uuid_89e9a5ca-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9a5d3-d990-11eb-1053-020000000000 | |||
Zorgverlener met id: uuid_89e9a5dc-d990-11eb-1053-020000000000 | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: uuid_89e9a5e6-d990-11eb-1053-020000000000 | |||
Zorgaanbieder met id: uuid_89e9a5d3-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Zorgaanbieder met id: uuid_89e9a5e6-d990-11eb-1053-020000000000 | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners |